vs

Side-by-side financial comparison of Baird Medical Investment Holdings Ltd (BDMD) and FIRST CAPITAL INC (FCAP). Click either name above to swap in a different company.

FIRST CAPITAL INC is the larger business by last-quarter revenue ($13.5M vs $8.0M, roughly 1.7× Baird Medical Investment Holdings Ltd). FIRST CAPITAL INC runs the higher net margin — 36.2% vs -142.7%, a 178.9% gap on every dollar of revenue. FIRST CAPITAL INC produced more free cash flow last quarter ($19.9M vs $-3.2M).

Baird Medical Investment Holdings Ltd is a healthcare-focused investment holding company mainly operating in the Chinese market. It invests in and manages businesses covering in vitro diagnostic devices, medical consumables, and community healthcare services, serving clinical institutions and individual consumers.

Capital First Ltd, formerly known as Future Capital Holdings, was an Indian non-bank financial institution which provided debt financing. In December 2018, it was merged into IDFC Bank to form IDFC First Bank. The company was listed on the NSE and BSE prior to the merger.

BDMD vs FCAP — Head-to-Head

Bigger by revenue
FCAP
FCAP
1.7× larger
FCAP
$13.5M
$8.0M
BDMD
Higher net margin
FCAP
FCAP
178.9% more per $
FCAP
36.2%
-142.7%
BDMD
More free cash flow
FCAP
FCAP
$23.2M more FCF
FCAP
$19.9M
$-3.2M
BDMD

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
BDMD
BDMD
FCAP
FCAP
Revenue
$8.0M
$13.5M
Net Profit
$-11.4M
$4.9M
Gross Margin
82.1%
Operating Margin
-131.3%
Net Margin
-142.7%
36.2%
Revenue YoY
19.0%
Net Profit YoY
49.6%
EPS (diluted)
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDMD
BDMD
FCAP
FCAP
Q4 25
$13.5M
Q3 25
$13.3M
Q2 25
$8.0M
$12.4M
Q1 25
$11.4M
Q4 24
$11.3M
Q3 24
$10.9M
Q2 24
$10.7M
Q1 24
$10.5M
Net Profit
BDMD
BDMD
FCAP
FCAP
Q4 25
$4.9M
Q3 25
$4.5M
Q2 25
$-11.4M
$3.8M
Q1 25
$3.2M
Q4 24
$3.3M
Q3 24
$2.9M
Q2 24
$2.8M
Q1 24
$3.0M
Gross Margin
BDMD
BDMD
FCAP
FCAP
Q4 25
Q3 25
Q2 25
82.1%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
BDMD
BDMD
FCAP
FCAP
Q4 25
Q3 25
41.8%
Q2 25
-131.3%
37.2%
Q1 25
34.2%
Q4 24
34.8%
Q3 24
31.5%
Q2 24
31.1%
Q1 24
33.0%
Net Margin
BDMD
BDMD
FCAP
FCAP
Q4 25
36.2%
Q3 25
33.8%
Q2 25
-142.7%
30.4%
Q1 25
28.3%
Q4 24
28.8%
Q3 24
26.5%
Q2 24
26.5%
Q1 24
28.1%
EPS (diluted)
BDMD
BDMD
FCAP
FCAP
Q4 25
$1.45
Q3 25
$1.34
Q2 25
$1.13
Q1 25
$0.97
Q4 24
$0.97
Q3 24
$0.87
Q2 24
$0.85
Q1 24
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDMD
BDMD
FCAP
FCAP
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$35.6M
$137.8M
Total Assets
$77.0M
$1.3B
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Total Debt
BDMD
BDMD
FCAP
FCAP
Q4 25
Q3 25
Q2 25
$8.4M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BDMD
BDMD
FCAP
FCAP
Q4 25
$137.8M
Q3 25
$132.4M
Q2 25
$35.6M
$123.2M
Q1 25
$120.1M
Q4 24
$114.6M
Q3 24
$116.8M
Q2 24
$107.8M
Q1 24
$105.7M
Total Assets
BDMD
BDMD
FCAP
FCAP
Q4 25
$1.3B
Q3 25
$1.2B
Q2 25
$77.0M
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$1.2B
Q1 24
$1.2B
Debt / Equity
BDMD
BDMD
FCAP
FCAP
Q4 25
Q3 25
Q2 25
0.24×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDMD
BDMD
FCAP
FCAP
Operating Cash FlowLast quarter
$-3.2M
$21.3M
Free Cash FlowOCF − Capex
$-3.2M
$19.9M
FCF MarginFCF / Revenue
-40.7%
147.7%
Capex IntensityCapex / Revenue
0.6%
10.0%
Cash ConversionOCF / Net Profit
4.36×
TTM Free Cash FlowTrailing 4 quarters
$35.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDMD
BDMD
FCAP
FCAP
Q4 25
$21.3M
Q3 25
$7.9M
Q2 25
$-3.2M
$3.7M
Q1 25
$4.4M
Q4 24
$22.3M
Q3 24
$7.6M
Q2 24
$3.5M
Q1 24
$7.2M
Free Cash Flow
BDMD
BDMD
FCAP
FCAP
Q4 25
$19.9M
Q3 25
$7.8M
Q2 25
$-3.2M
$3.5M
Q1 25
$4.2M
Q4 24
$21.6M
Q3 24
$7.5M
Q2 24
$3.3M
Q1 24
$7.1M
FCF Margin
BDMD
BDMD
FCAP
FCAP
Q4 25
147.7%
Q3 25
58.6%
Q2 25
-40.7%
27.8%
Q1 25
36.5%
Q4 24
190.7%
Q3 24
68.6%
Q2 24
31.2%
Q1 24
67.2%
Capex Intensity
BDMD
BDMD
FCAP
FCAP
Q4 25
10.0%
Q3 25
1.2%
Q2 25
0.6%
2.2%
Q1 25
1.9%
Q4 24
6.3%
Q3 24
0.8%
Q2 24
1.4%
Q1 24
1.5%
Cash Conversion
BDMD
BDMD
FCAP
FCAP
Q4 25
4.36×
Q3 25
1.77×
Q2 25
0.99×
Q1 25
1.36×
Q4 24
6.84×
Q3 24
2.62×
Q2 24
1.23×
Q1 24
2.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons